102 related articles for article (PubMed ID: 36967501)
1. Fucoidan enhances the effect of chemotherapeutic drug against drug-resistant lung cancer cells.
Tsao DA; Wang YC; Chien ST; Lin SY; Chang HR
Pak J Pharm Sci; 2023 Jan; 36(1):89-97. PubMed ID: 36967501
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy.
Zhang N; Xue M; Wang Q; Liang H; Yang J; Pei Z; Qin K
Phytother Res; 2021 Dec; 35(12):6904-6917. PubMed ID: 34687482
[TBL] [Abstract][Full Text] [Related]
3. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
[TBL] [Abstract][Full Text] [Related]
4. Dehydrocostus Lactone Enhances Chemotherapeutic Potential of Doxorubicin in Lung Cancer by Inducing Cell Death and Limiting Metastasis.
Sheng W; Mao H; Wang C; Yang N; Zhang Z; Han J
Med Sci Monit; 2018 Nov; 24():7850-7861. PubMed ID: 30388099
[TBL] [Abstract][Full Text] [Related]
5. Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells.
He X; Xue M; Jiang S; Li W; Yu J; Xiang S
Biol Pharm Bull; 2019; 42(3):442-447. PubMed ID: 30828076
[TBL] [Abstract][Full Text] [Related]
6. Phytohemagglutinin from Phaseolus vulgaris enhances the lung cancer cell chemotherapy sensitivity by changing cell membrane permeability.
Wang P; Min S; Chen C; Hu J; Wei D; Wang X
J Nat Med; 2024 Mar; 78(2):355-369. PubMed ID: 38265611
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Effects of Fucoidan Via Apoptotic and Autophagic Induction on HSC-3 Oral Squamous CellCarcinoma.
Chantree P; Surarak T; Sangpairoj K; Aguilar P; Hitakomate E
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2469-2477. PubMed ID: 32856880
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.
Kang JH; Song KH; Jeong KC; Kim S; Choi C; Lee CH; Oh SH
BMC Cancer; 2011 Aug; 11():334. PubMed ID: 21813027
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer.
Hsu HY; Lin TY; Lu MK; Leng PJ; Tsao SM; Wu YC
Sci Rep; 2017 Mar; 7():44990. PubMed ID: 28332554
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
Hsu HY; Lin TY; Hu CH; Shu DTF; Lu MK
Cancer Lett; 2018 Sep; 432():112-120. PubMed ID: 29746926
[TBL] [Abstract][Full Text] [Related]
11. Emodin: One Main Ingredient of Shufeng Jiedu Capsule Reverses Chemoresistance of Lung Cancer Cells Through Inhibition of EMT.
Ying Y; Qingwu L; Mingming X; Zhenju S; Chaoyang T; Zhengang T
Cell Physiol Biochem; 2017; 42(3):1063-1072. PubMed ID: 28662514
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells.
Park HS; Kim GY; Nam TJ; Deuk Kim N; Hyun Choi Y
J Food Sci; 2011 Apr; 76(3):T77-83. PubMed ID: 21535865
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect and molecular mechanism of fucoidan in NSCLC.
Chen X; Sun L; Wei X; Lu H; Tan Y; Sun Z; Jiang J
BMC Complement Med Ther; 2021 Jan; 21(1):25. PubMed ID: 33430854
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells.
Kang S; Kang K; Chae A; Kim YK; Jang H; Min DH
Nanoscale; 2019 Aug; 11(32):15173-15183. PubMed ID: 31380881
[TBL] [Abstract][Full Text] [Related]
15. Diterpene promptly executes a non-canonical autophagic cell death in doxorubicin-resistant lung cancer.
Chiu WJ; Lin CS; Lin SR; Chen TH; Wu CJ; Busa P; Long H; Chen CC; Tseng FJ; Fu YS; Weng CF
Biomed Pharmacother; 2022 Sep; 153():113443. PubMed ID: 36076558
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation.
Hsu HY; Lin TY; Wu YC; Tsao SM; Hwang PA; Shih YW; Hsu J
Oncotarget; 2014 Sep; 5(17):7870-85. PubMed ID: 25149540
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression.
Qiu WL; Tseng AJ; Hsu HY; Hsu WH; Lin ZH; Hua WJ; Lin TY
Int J Biol Macromol; 2020 Jun; 153():796-805. PubMed ID: 32169452
[TBL] [Abstract][Full Text] [Related]
18. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell Lung Cancer.
Liao X; Cai R; Li G; Chen F
Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan Inhibits the Proliferation of Leiomyoma Cells and Decreases Extracellular Matrix-Associated Protein Expression.
Chen HY; Huang TC; Lin LC; Shieh TM; Wu CH; Wang KL; Hong YH; Hsia SM
Cell Physiol Biochem; 2018; 49(5):1970-1986. PubMed ID: 30235439
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling.
Kim BS; Park JY; Kang HJ; Kim HJ; Lee J
Biochem Biophys Res Commun; 2014 Aug; 450(4):1333-8. PubMed ID: 25003321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
